Literature DB >> 12822615

Optimal treatment of type B acute aortic dissection: long-term medical follow-up results.

Mitsumasa Hata1, Motomi Shiono, Tatsuya Inoue, Akira Sezai, Tetsuya Niino, Nanao Negishi, Yukiyasu Sezai.   

Abstract

BACKGROUND: The aim of this study is to assess the long-term outcome of medical treatment and determine recent surgical indications for type B acute aortic dissection.
METHODS: In the last 8 years, 79 patients were admitted to our hospital with type B acute aortic dissection. We medically treated patients at the time of onset, regardless of the aortic diameter and blood patency status in the false lumen. If the maximum diameter of dissected aorta exceeded 60 mm in any stage, early or elective surgery was performed. The mean follow-up duration was 41.2 months. We evaluated operation free rate and actuarial survival rate.
RESULTS: Thirteen patients underwent early or elective operations of the descending aorta. At the time of onset, the maximum aortic diameter of these patients was significantly larger than that of medically managed patients (55.8 +/- 4.4 mm vs 44.6 +/- 8.2 mm; p = 0.0004). Two patients underwent emergency axillo-femoral bypass for leg ischemia. Of the other 64 patients, who were medically managed, 2 patients had type A dissection develop during follow-up, 3 died during the initial hospital stay (1 from rupture, 1 from bronchial asthma, and 1 from gut ischemia), and 1 died of pneumonia 6 months after onset. Operation free rate was 98.6% at 1 month, 90.0% at 1 year, 78.7% at 3 years, and 69.5% at 8 years. Actuarial survival rate of medically managed patients was 98.4% at 1 month and 93.5% at 8 years.
CONCLUSIONS: Medical treatment of type B acute aortic dissection produced good results. Surgical intervention for type B dissection should be done when the maximum aortic diameter exceeds 60 mm.

Entities:  

Mesh:

Year:  2003        PMID: 12822615     DOI: 10.1016/s0003-4975(03)00113-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Aortic dissection is associated with intermittent hypoxia and re-oxygenation.

Authors:  Ryo Naito; Kenichi Sakakura; Takatoshi Kasai; Tomotaka Dohi; Hiroshi Wada; Yoshitaka Sugawara; Norifumi Kubo; Suguru Yamashita; Koji Narui; Sugao Ishiwata; Minoru Ohno; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-05-15       Impact factor: 2.037

Review 2.  Acute complicated and uncomplicated type III aortic dissection: an endovascular perspective.

Authors:  Castigliano M Bhamidipati; Gorav Ailawadi
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

3.  Efficacy of thoracic endovascular stent repair for chronic type B aortic dissection with aneurysmal degeneration.

Authors:  Salvatore T Scali; Robert J Feezor; Catherine K Chang; David H Stone; Philip J Hess; Tomas D Martin; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2013-04-03       Impact factor: 4.268

Review 4.  Retrograde Type A Aortic Dissection After Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-Analysis.

Authors:  Yanqing Chen; Simeng Zhang; Lei Liu; Qingsheng Lu; Tianyi Zhang; Zaiping Jing
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

5.  The new indication of TEVAR for uncomplicated type B aortic dissection.

Authors:  Chao Song; Qingsheng Lu; Jian Zhou; Guanyu Yu; Xiang Feng; Zhiqing Zhao; Junmin Bao; Rui Feng; Zaiping Jing
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

6.  One-Year Single-Center Results of the Multilayer Flow Modulator Stents for the Treatment of Type B Aortic Dissection.

Authors:  Victor S Costache; Jorn P Meekel; Andreea Costache; Tatiana Melnic; Cristian Bucurenciu; Anca Chitic; Gabriela Candea; Crina Solomon; Kak K Yeung
Journal:  J Endovasc Ther       Date:  2020-09-01       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.